PLoS ONE (Jan 2013)

Increasing the yield in targeted next-generation sequencing by implicating CNV analysis, non-coding exons and the overall variant load: the example of retinal dystrophies.

  • Tobias Eisenberger,
  • Christine Neuhaus,
  • Arif O Khan,
  • Christian Decker,
  • Markus N Preising,
  • Christoph Friedburg,
  • Anika Bieg,
  • Martin Gliem,
  • Peter Charbel Issa,
  • Frank G Holz,
  • Shahid M Baig,
  • Yorck Hellenbroich,
  • Alberto Galvez,
  • Konrad Platzer,
  • Bernd Wollnik,
  • Nadja Laddach,
  • Saeed Reza Ghaffari,
  • Maryam Rafati,
  • Elke Botzenhart,
  • Sigrid Tinschert,
  • Doris Börger,
  • Axel Bohring,
  • Julia Schreml,
  • Stefani Körtge-Jung,
  • Chayim Schell-Apacik,
  • Khadijah Bakur,
  • Jumana Y Al-Aama,
  • Teresa Neuhann,
  • Peter Herkenrath,
  • Gudrun Nürnberg,
  • Peter Nürnberg,
  • John S Davis,
  • Andreas Gal,
  • Carsten Bergmann,
  • Birgit Lorenz,
  • Hanno J Bolz

DOI
https://doi.org/10.1371/journal.pone.0078496
Journal volume & issue
Vol. 8, no. 11
p. e78496

Abstract

Read online

Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are major causes of blindness. They result from mutations in many genes which has long hampered comprehensive genetic analysis. Recently, targeted next-generation sequencing (NGS) has proven useful to overcome this limitation. To uncover "hidden mutations" such as copy number variations (CNVs) and mutations in non-coding regions, we extended the use of NGS data by quantitative readout for the exons of 55 RP and LCA genes in 126 patients, and by including non-coding 5' exons. We detected several causative CNVs which were key to the diagnosis in hitherto unsolved constellations, e.g. hemizygous point mutations in consanguineous families, and CNVs complemented apparently monoallelic recessive alleles. Mutations of non-coding exon 1 of EYS revealed its contribution to disease. In view of the high carrier frequency for retinal disease gene mutations in the general population, we considered the overall variant load in each patient to assess if a mutation was causative or reflected accidental carriership in patients with mutations in several genes or with single recessive alleles. For example, truncating mutations in RP1, a gene implicated in both recessive and dominant RP, were causative in biallelic constellations, unrelated to disease when heterozygous on a biallelic mutation background of another gene, or even non-pathogenic if close to the C-terminus. Patients with mutations in several loci were common, but without evidence for di- or oligogenic inheritance. Although the number of targeted genes was low compared to previous studies, the mutation detection rate was highest (70%) which likely results from completeness and depth of coverage, and quantitative data analysis. CNV analysis should routinely be applied in targeted NGS, and mutations in non-coding exons give reason to systematically include 5'-UTRs in disease gene or exome panels. Consideration of all variants is indispensable because even truncating mutations may be misleading.